Podium Sessions
Presentations are strictly limited to 10 minutes: 7-minute talk followed by 3-minute discussion. Please upload your presentation (.pptx or .pdf file) at the speakers-ready room not later than 3h before the scheduled presentation time. Preferred slide format: 16:9
Oral Poster Sessions
Oral poster presentations are strictly limited to a 1-minute talk followed by a 2- minute discussion (one question for each presenter). Please prepare one slide only and upload your presentation (.pptx or .pdf file) at the speakers-ready room not later than 3h before the scheduled presentation time. Please also bring a printed poster in A0 format, portrait orientation. Preferred slide format: 16:9
Poster Sessions
Please prepare a printed poster in A0 format in portrait orientation. Posters should be displayed from September 7 to September 9.
Publication - All selected abstracts will appear in full on the Conference website, abstract booklet, as well as in Orthopaedic Proceedings. By submitting your abstract, you give permission for their publication unless otherwise notified.
Submission process - In order to submit your abstract, you will need to register an email address with the Oxford Abstracts system. Once you have done so, you will be taken to a dashboard that will allow you to submit or amend your abstract. Please be aware that some local firewalls may restrict access to the abstract submission website, so if you are experiencing problems, please either try to access the site from another machine or ensure that you have added Oxford Abstracts as a ‘Trusted Sender’. Please enter an abstract of your paper (max 300 words, maximum one figure and/or table is permitted).
For research abstracts use headings:
• Objective
• Methods
• Results
• Conclusions
Research abstracts containing no data are unlikely to be accepted, you must include results unless you are describing a clinical case. Make sure sample size is clearly stated (whether this is number of replicates/test repeats or cohort size).
For clinical cases use headings:
• Background
• Presenting problem or Methods
• Clinical management or Results
• Discussion
Please note that any incomplete abstract submissions will not be considered for review. Abstracts should be carefully checked for spelling, grammar, missing data, blank pages, and any duplications, prior to submission to us. We do not perform any editing on the abstracts other than the deletion of inadmissible material.
• Spelling - For English spelling, if possible use the Concise Oxford Dictionary or The Oxford Dictionary for Writers and Editors. Note, however, the following: - Use “ise” not “ize” spellings.
• Underlining/Italic Type - Underlining, or italic type may be used to stress words or phrases. Latin names should be underlined, or set in italics if available.
• Capitals - Use capitals for proper names, titles, geographical names, trade names.
• Abbreviations - Abbreviations not in common use should be spelled out in full the first time they occur in a typescript, followed by the abbreviation in brackets. - Examples: Greenwich Mean Time (GMT).
• Short names (of countries, institutions, honours) and well-known acronyms are abbreviated without full stops and without a space between the letters. - Examples: USA, UK, PM (Prime Minister), ESR, WBC, FRS, BA
• Decimals - 6.9 (point on line), 0.78 (not 78), 1.5), 20 g (not 20.0 g); one-half, three-quarters (in text only)
All abstracts must be completed and submitted before the deadline.
Review and Selection - The review of abstracts will take place in February and March 2022. Each abstract will be reviewed by academics who are experts on the specific topic that corresponds to the content of the abstract. Once all abstracts are reviewed and scored, the highest ranking abstracts will be selected to be included in the Congress programme in free paper sessions. Abstracts selected will either be presented as podium or poster presentations during the meeting.
While we are planning to host a physical event, this is subject to COVID-19 restrictions. In the event that we are prohibited from having a full delegation, we will look to deliver the meeting either as a hybrid or fully virtual event. We would therefore recommend that your podium or poster presentations are adaptable to either a physical or virtual format. Any abstracts submitted that have been published previously may not be selected.
Notification - Abstract authors will receive a notification regarding their submission May 2022 Please be aware that notifications will be sent to the email address of the presenting author. All presenting authors must register to attend the meeting in order to present their abstract as a Podium or Poster presentation. There is no discounted registration rate for presenting authors. Should you have any queries please contact the ICORS Events Team at ICORS2022@ed.ac.uk
The International Combined Orthopaedic Research Societies (ICORS) serves as an alliance of societies to promote basic, translational, and clinical musculoskeletal research worldwide. The Combined Meeting was launched in 1992 and has convened every three years since On October 15, 2013, at the 8th Combined Meeting of the Orthopaedic Research Societies hosted by the European Orthopaedic Research in Venice, Italy, a new alliance was formed; the International Combined Orthopaedic Research Societies. Nine organizations were selected and approved as the founding members; Australia/New Zealand ORS, British ORS, Canadian ORS, Chinese ORS, European ORS, Japanese Orthopaedic Association, Korean ORS, the Orthopaedic Research Society, and the Taiwanese ORS.
ICORS 2022 Disclaimer
If you have any questions or suggestions, please contact us: ICORS2022CHARACTER SEQUENCE@ed.ac.uk or click to email.